1. Home
  2. XLO vs CAPT Comparison

XLO vs CAPT Comparison

Compare XLO & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • CAPT
  • Stock Information
  • Founded
  • XLO 2016
  • CAPT 2005
  • Country
  • XLO United States
  • CAPT South Korea
  • Employees
  • XLO N/A
  • CAPT N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • CAPT Blank Checks
  • Sector
  • XLO Health Care
  • CAPT Finance
  • Exchange
  • XLO Nasdaq
  • CAPT Nasdaq
  • Market Cap
  • XLO 35.7M
  • CAPT 37.9M
  • IPO Year
  • XLO 2021
  • CAPT N/A
  • Fundamental
  • Price
  • XLO $0.81
  • CAPT $0.94
  • Analyst Decision
  • XLO Buy
  • CAPT
  • Analyst Count
  • XLO 2
  • CAPT 0
  • Target Price
  • XLO $3.00
  • CAPT N/A
  • AVG Volume (30 Days)
  • XLO 453.9K
  • CAPT 158.0K
  • Earning Date
  • XLO 11-06-2025
  • CAPT 01-01-0001
  • Dividend Yield
  • XLO N/A
  • CAPT N/A
  • EPS Growth
  • XLO N/A
  • CAPT N/A
  • EPS
  • XLO N/A
  • CAPT N/A
  • Revenue
  • XLO $15,001,000.00
  • CAPT $17,389,944.00
  • Revenue This Year
  • XLO $519.70
  • CAPT N/A
  • Revenue Next Year
  • XLO $44.57
  • CAPT N/A
  • P/E Ratio
  • XLO N/A
  • CAPT N/A
  • Revenue Growth
  • XLO 536.45
  • CAPT 84.70
  • 52 Week Low
  • XLO $0.62
  • CAPT $0.37
  • 52 Week High
  • XLO $1.70
  • CAPT $2.14
  • Technical
  • Relative Strength Index (RSI)
  • XLO 62.62
  • CAPT 39.67
  • Support Level
  • XLO $0.79
  • CAPT $0.83
  • Resistance Level
  • XLO $0.91
  • CAPT $1.05
  • Average True Range (ATR)
  • XLO 0.04
  • CAPT 0.06
  • MACD
  • XLO 0.00
  • CAPT -0.01
  • Stochastic Oscillator
  • XLO 50.46
  • CAPT 25.42

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About CAPT Captivision Inc.

Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.

Share on Social Networks: